Merck
CN

HPLC Analysis of Native and Oxidized Filgrastim on BIOshell A400 Protein C4 Column

HPLC Analysis of Native and Oxidized Filgrastim on BIOshell A400 Protein C4 Column application for HPLC

材料

分析色谱柱

产品编号
说明
价格

BIOshell A400 Protein C4, 3.4 μm HPLC Column

3.4 μm particle size, L × I.D. 10 cm × 2.1 mm

试剂

产品编号
说明
价格

过氧化氢 溶液

30 % (w/w) in H2O, contains stabilizer

CONDITIONS

column

BIOshell A400 Protein C4, 10 cm x 2.1 mm I.D., 3.4 μm particles (66825-U)

mobile phase

[A] Water (0.1% trifluoroacetic acid); [B] Acetonitrile (0.1% trifluoroacetic acid)

gradient

55 to 70% B in 5 min.

flow rate

0.2 mL/min

pressure

590 psi (41 bar)

column temp.

60 °C

detector

UV, 215 nm

injection

1 μL

sample

Native Filgrastim, 98 μg/mL, Water
Oxidized Filgrastim, 98 μg/mL, 0.1% Hydrogen peroxide

说明

分析说明

Filgrastim is a 175 amino acid polypeptide produced by recombinant DNA technology in genetically engineered Escherichia coli cells. This protein is used as a biosimilar to granulocyte colony-stimulating factor (GCSF) to treat neutropenia, a disease characterized by a low concentration of neutrophils in a person′s blood due to chemotherapy, bone marrow transplantation, or genetic predisposition. Common impurities found in this biosimilar are oxidized filgrastim variants which are produced by the oxidation of methionine side chains (sulfhydryl oxidation to the sulfoxide). In a sample of filgrastim that had been stressed with dilute (0.1%) hydrogen peroxide, four oxidized variants can be resolved from native (i.e. unoxidized) filgrastim on a BIOshell A400 Protein C4 column. The top chromatogram shows native filgrastim and the bottom chromatogram shows filgrastim after oxidative stressing.

其他说明

Oxidized filgrastim sample was prepared by mixing 50 μL of a 980 μg/mL filgrastim standard solution with 450 μL of 0.1% hydrogen peroxide and allowing the sample to equilibrate at room temperature for five hours prior to assay.

法律信息

null